Vasodilation for Vasospastic Hypertension
- 26 July 1973
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 289 (4) , 213-214
- https://doi.org/10.1056/nejm197307262890411
Abstract
Accelerated or malignant hypertension is a progressive vasospastic disease characterized by rapidly increasing peripheral vascular resistance. Arterial pressure must be quickly and effectively reduced to halt arteriolar deterioration and to prevent advancing renal damage, hemorrhagic complications, or hypertensive encephalopathy. In most patients this decrease can be accomplished with a variety of antihypertensive drugs or drug combinations. Only a few cases of accelerated hypertension fail or cease to respond satisfactorily to the commonly employed agents. Such cases have been labeled "refractory" hypertension, and some have been treated with bilateral nephrectomies.Lack of adequate response to the usual antihypertensive drugs should not . . .Keywords
This publication has 10 references indexed in Scilit:
- Minoxidil in severe hypertension with renal failure: Effect of its addition to conventional antihypertensive drugsThe American Journal of Cardiology, 1973
- Hemodynamic comparison of agents useful in hypertensive emergenciesAmerican Heart Journal, 1973
- Propranolol Inhibition of Renin SecretionNew England Journal of Medicine, 1972
- The effect of guancydine on blood pressure, vascular reactivity, and norepinephrine uptake in essential hypertensionClinical Pharmacology & Therapeutics, 1972
- Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular diseaseThe American Journal of Medicine, 1972
- Guancydine: A New Antihypertensive AgentAnnals of Internal Medicine, 1972
- Treatment of Essential Hypertension with Combined Vasodilation and Beta-Adrenergic BlockadeNew England Journal of Medicine, 1972
- Combined Therapy with Vasodilator Drugs and Beta-Adrenergic Blockade in HypertensionCirculation, 1972
- Hemodynamic and therapeutic effects of guancydine in hypertensionClinical Pharmacology & Therapeutics, 1971
- Treatment of Essential Hypertension with a New Vasodilator in Combination with Beta-Adrenergic BlockadeNew England Journal of Medicine, 1970